STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)			1 Months Ended							3 Months Ended		6 Months Ended
	May 03, 2021	Mar. 31, 2021	Jun. 30, 2021	May 31, 2021	Jan. 31, 2021	Jun. 30, 2020	Feb. 29, 2020	Nov. 30, 2019	Apr. 30, 2019	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2021	Jun. 30, 2020
Class of Stock [Line Items]
Share-based Payment Arrangement, Expense							$ 2,100,000				$ 0	$ 2,000,000.0	$ 2,100,000
Proceeds from Issuance of Common Stock												$ 70,108
Preferred Stock [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities											(278,188)
Number of shares issued during the period		278,188
Common Stock [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities		278,187,847									278,187,847
Number of shares issued during the period										400,000
TFK Investments LLC [Member]
Class of Stock [Line Items]
Number of shares issued during the period					657,200	750,000
TFK Investments LLC [Member] | Convertible Notes Payable [Member]
Class of Stock [Line Items]
Number of shares issued during the period						1,012,145
TFK Investments LLC [Member] | Preferred Stock [Member]
Class of Stock [Line Items]
Convertible Preferred Stock, Shares Issued upon Conversion			278,188							278,188		278,188
TFK Investments LLC [Member] | Common Stock [Member]
Class of Stock [Line Items]
Convertible Preferred Stock, Shares Issued upon Conversion			278,187,847							278,187,847		278,187,847
Peak One [Member]
Class of Stock [Line Items]
Number of shares issued during the period						500,000	500,000
Peak One [Member] | Convertible Notes Payable [Member]
Class of Stock [Line Items]
Number of shares issued during the period							1,200,000
Mateon Therapeutics Inc [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities						569,800
Series A Preferred Stock [Member] | TFK Investments LLC [Member]
Class of Stock [Line Items]
Convertible Preferred Stock, Shares Issued upon Conversion			278,188							278,188		278,188
Merger Agreement [Member] | Series A Preferred Stock [Member] | Oncotelic [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities									193,713
Number of shares issued during the period									77,154
Merger Agreement [Member] | Series A Preferred Stock [Member] | PointR [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities								11,135,935
Number of shares issued during the period								84,475
Equity Purchase Agreement and Registration Rights Agreement [Member]
Class of Stock [Line Items]
Sale of Stock, Number of Shares Issued in Transaction			400,000							400,000
Proceeds from Issuance of Common Stock			$ 70,000							$ 99,000
Equity Purchase Agreement and Registration Rights Agreement [Member] | Minimum [Member]
Class of Stock [Line Items]
Sale of Stock, Price Per Share	$ 0.15		$ 0.15							$ 0.15		$ 0.15
Equity Purchase Agreement and Registration Rights Agreement [Member] | Maximum [Member]
Class of Stock [Line Items]
Sale of Stock, Price Per Share	$ 0.23		$ 0.23							$ 0.23		$ 0.23
Equity Purchase Agreement and Registration Rights Agreement [Member] | Peak One Opportunity Fund, L.P [Member]
Class of Stock [Line Items]
Number of shares issued during the period	250,000			250,000
Share-based Payment Arrangement, Expense	$ 70,000